Director, US GI Market Research

Revolution Medicines•Redwood City, CA

4d•Hybrid

About The Position

Revolution Medicines is a global, commercial-stage oncology company focused on discovering, developing, and delivering medicines for patients with RAS-addicted cancers. The Director, US GI Market Research will lead US market research for the company’s GI cancer portfolio and report to the Senior Director, US GI Analytics & Insights. The role partners with US Commercial, US Market Access, Global Market Research, Medical Affairs, Clinical Development, and Business Operations to generate insights for portfolio strategy, launch readiness, commercialization planning, and business performance. The position is based at the Redwood City, California headquarters, with flexibility for remote candidates who are willing to travel regularly to the office. The Director conducts research and synthesizes market understanding across the PDAC and CRC treatment landscapes, patient journeys, biomarker-driven markets, and oncology data assets. The role also develops recommendations for stakeholders and senior leadership, supports launch planning, and works with analytics, forecasting, and competitive intelligence colleagues to understand market performance and growth opportunities.

Requirements

Bachelor’s degree required.
10 or more years of progressive experience in pharmaceutical, biotechnology, or strategic consulting roles.
At least 6 years of experience in a strategic analytics role.
Oncology market research experience.
Experience in market development and new product launches.
Extensive primary research and secondary analytical skills, with the ability to translate data and learning into actionable business-growth recommendations.
Collaborative and adaptive approach suited to the needs of a growing business.
Problem-solving experience using varied research and analytical vendors and study designs, and building quality research vendor partnerships.
Demonstrated ability to influence senior management and key business partners.
Proven experience in a smaller, rapidly growing company.
Excellent organizational skills and ability to prioritize and deliver within reasonably established timelines.
Strong interpersonal, verbal, and written communication skills and ability to represent Revolution Medicines with internal and external stakeholders.
Entrepreneurial mindset, tolerance for ambiguity, and passion for helping cancer patients.

Nice To Haves

Advanced degree.
GI cancer experience, especially PDAC and/or CRC.
MBA, MPH, MS, or PhD.
Deep understanding of PDAC and/or CRC and biomarker-driven oncology markets.
Experience supporting targeted oncology therapies.
Prior experience in a growth-stage biotechnology company.

Responsibilities

Lead, design, and execute US primary market research projects with healthcare professionals, patients, and payors.
Develop activities that improve partners’ understanding of the US market, product attitudes and usage, market dynamics, and competition, including treatment flows, target product profiles, opportunity assessments, and market landscape research.
Represent the voice of the US community, including physicians, patients, and payors, by synthesizing primary and secondary sources into a holistic view of the marketplace.
Reinforce market research best practices and identify appropriate research and data sources, vendors, and methodologies for business needs.
Manage third parties associated with the market research function.
Align internal stakeholders on research objectives and outputs, qualify findings based on data strength, and identify limitations.
Develop and present timely final reports and actionable recommendations to stakeholders and senior leadership, emphasizing key findings and relevant implications.
Communicate insights and strategic implications to senior leadership through clear, concise, and compelling recommendations.
Shape situation analysis for launch planning to provide a comprehensive understanding of the market.
Partner with cross-functional teams, including marketing, sales when appropriate, market access, and medical, to provide a clear view of the market.
Assess complex markets, disease states, competitive landscapes, and market and managed care dynamics.
Evaluate business opportunities and quantify risks with analytical rigor.
Partner with US Forecasting, US Data Analytics, and Competitive Intelligence colleagues to develop an integrated view of market performance and future growth opportunities.
Travel as needed.